Researchers have reported results of clinical research on new presbyopia treatments now available in Europe, and possibly available soon in the United States.
Category: News
Wavefront-Optimized Vision Correction Improves Uncorrected Distance Visual Acuity
A transition from wavefront-guided correction to wavefront-optimized ablation with an excimer laser platform proved successful and resulted in strong visual outcomes, a study showed.
AAO: Can Boomers Throw Away Their Reading Glasses?
With the baby-boom generation now firmly in the age range when near-range vision goes blurry, advances in refractive surgery and implants could allow many of them to do away with reading glasses, researchers said here.
Wavefront-Optimized Vision Correction Improves Uncorrected Distance Visual Acuity
A transition from wavefront-guided correction to wavefront-optimized ablation with an excimer laser platform proved successful and resulted in strong visual outcomes, a study showed.
Alcon Independent Director Committee Notes Change In Alcon Chairmanship
The Alcon Independent Director Committee (the “IDC”) notes that Dr. Daniel Vasella, Chairman of Novartis AG (“Novartis”), replaced Mr. Cary Rayment as Chairman of the Alcon Board of Directors at a telephonic meeting of the Alcon Board of Directors held…
ECTRIMS 2010: Orals, Retinal Imaging, and Other Highlights
Dr. Andrew N. Wilner highlights new diagnostic and therapeutic data presented at ECTRIMS 2010. Medscape Neurology & Neurosurgery
Anorexia Nervosa May Cause Serious Harm to Patients’ Eyes
The damage is worse in those who binge and purge. Medscape Medical News
Vitamin D Deficiency Associated With Diabetic Retinopathy
A daily multivitamin is “somewhat protective” against diabetic retinopathy, study author says. Medscape Medical News
Xalatan Receives Paediatric Indication In Europe
Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with elevated intraocular pressure and paediatric glaucoma. L…
Time is on Novartis Side in Alcon Bid
Novartiss bet that with time it would win over Alcon Inc.s shareholders seems to be paying off. Since the Swiss pharma giant bought a majority stake in the eye-care firm earlier this year, resistance from Alcons minority shareholders to Novartiss off…
Garamycin Ophthalmic Ointment Now Available from Fera Pharmaceuticals
Fera Pharmaceuticals announced the launch today of preservative free Garamycin (gentamicin sulfate) Ophthalmic Ointment USP. Providing an alternate gentamicin formulation, without preservatives, was an unmet need Fera was glad to fill. When Erythromy…
American Academy Of Ophthalmology Joint Meeting Marked By Academy Firsts And Strong Turnout
Academy firsts and strong turnout marked the largest and most comprehensive ophthalmic educational meeting in the world…
Contact Lenses: A Safe Option When Used Properly
For 40 million Americans, using contact lenses to improve vision is a way of life. While a good number adhere to the medical guidelines for wearing contacts, according to the American Optometric Association’s (AOA) annual American Eye-Q® survey, many …
Xalatan(R) Receives Paediatric Indication In Europe
Pfizer announced that Xalatan 0.005% (latanoprost) has been approved by the European Commission for reduction of elevated intraocular pressure (IOP) in the treatment of paediatric patients with elevated intraocular pressure and paediatric glaucoma…
Drug Companies Influence Prescribing, Study Finds
Doctors tend to prescribe drugs that pharmaceutical companies promote to them and patients end up paying more but not always getting the most suitable medicines, researchers reported on Wednesday. Reuters Health Information
AAO Joint Meeting Marked by Academy Firsts and Strong Turnout
Academy firsts and strong turnout marked the largest and most comprehensive ophthalmic educational meeting in the world. The American Academy of Ophthalmologys (Academy) 2010 Joint Meeting in conjunction with the Middle East Africa Council of Ophthal…
AAO: Uveitis Tx Falls Short of Recommendations (CME/CE)
CHICAGO (MedPage Today) — Most ophthalmologists do not rely on evidence-based treatment guidelines for uveitis and, perhaps as a result, their practice patterns often deviated substantially from the recommendations, a survey showed.
New Clinical Data On Meriva Show Eye Inflammations Reduction
A new clinical study published in Clinical Ophthalmology shows that Meriva, an Indena proprietary complex of curcumin with soy phosphatidylcholine, can play an important role in the adjunctive therapy of recurrent anterior uveitis (RAU), the most com…
Novartis Third-Quarter Net Rises on Lucentis, Exforge
Novartis AG indicated Alcon Inc. shareholders should take another look at its $11.5 billion buyout offer now that an increase in the Swiss drugmakers share price and a rally in the franc have lifted the value of the bid. Novartis, which owns 77 perce…
Alcon 3Q profit falls on Novartis deal costs
Alcon Inc., which makes treatments for glaucoma and eye infections, said Wednesday its third-quarter net income fell 13 percent on costs related to its majority takeover by fellow Swiss drugmaker Novartis SA. Still the results topped analysts’ expect…